ThomasP.LoughranJr.MD
Oncology • Charlottesville, VAProfessor, Medicine,University of Virginia Director, University of Virginia Cancer Center
Dr. Loughran is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1240 Lee St
Charlottesville, VA 22908Phone+1 434-924-9926Fax+1 434-243-6086- Is this information wrong?
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 1982 - 1985
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1979 - 1982
Drexel University College of MedicineClass of 1979
Certifications & Licensure
VA State Medical License 2013 - 2024
PA State Medical License 1980 - 2014
FL State Medical License 1996 - 2005- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Member of Board of Directors Association of American Cancer Institutes, 2018-2021
- First Annual Distinguished Alumni Lecture Thomas Jefferson University, 2011
- Ursinus College Alumni Award 2010
- Join now to see all
Clinical Trials
- Arsenic Trioxide for Induction Therapy of Adult Patients With Leukemia Start of enrollment: 2000 Aug 01
- Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia Start of enrollment: 2006 May 01
- Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome Start of enrollment: 2007 Apr 01
Publications & Presentations
PubMed
- 2 citationsEffective treatment with the selective cytokine inhibitor BNZ-1 reveals the cytokine dependency of T-LGL leukemia.Jonathan E Brammer, Karen Ballen, Lubomir Sokol, Christiane Querfeld, Ryotaro Nakamura, Anjali Mishra, Eric M McLaughlin, David Feith, Nazli Azimi, Thomas A Waldmann, ...> ;Blood. 2023 Oct 12
- 6 citationsTγδ LGLL identifies a subset with more symptomatic disease: analysis of an international cohort of 137 patients.Gregorio Barilà, Angela Grassi, HeeJin Cheon, Antonella Teramo, Giulia Calabretto, Jasmanet Chahal, Cristina Vicenzetto, Julia Almeida, Bryna C Shemo, Min Shi, Vanessa...> ;Blood. 2023 Mar 2
- 7 citationsCeramide nanoliposomes augment the efficacy of venetoclax and cytarabine in models of acute myeloid leukemia.Andrei V Khokhlatchev, Arati Sharma, Tye G Deering, Jeremy J P Shaw, Pedro Costa-Pinheiro, Upendarrao Golla, Charyguly Annageldiyev, Myles C Cabot, Mark R Conaway, Su-...> ;FASEB Journal. 2022 Oct 1
- Join now to see all
Other
- Natural killer (NK) cell large granular lymphocyte leukemiaLoughran TP, Lamy T
http://www.uptodate.com/contents/natural-killer-nk-cell-large-granular-lymphocyte-leukemia
UpToDate, Wolters Kluwer Health - 2012-09-10 - Treatment of large granular lymphocyte leukemiaLoughran TP, Lamy T
http://www.uptodate.com/contents/treatment-of-large-granular-lymphocyte-leukemia
UpToDate, Wolters Kluwer Health - 2012-03-30 - Clinical manifestations, pathologic features, and diagnosis of T cell large granular lymphocyte leukemiaLoughran TP, Lamy T
http://www.uptodate.com/contents/clinical-manifestations-pathologic-features-and-diagnosis-of-t-cell
UpToDate, Wolters Kluwer Health - 2012-11-26
Press Mentions
Top Docs 2021April 26th, 2021
Top Docs 2020April 27th, 2020
Q&A: Cancer Death Rates Are Falling Nationally. Here’s What’s Happening at UVAJanuary 10th, 2020- Join now to see all
Hospital Affiliations
UVA Health Culpeper Medical CenterCulpeper, Virginia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
